| P50 | author | Jan-Peter Smedema | Q89119041 |
| | Hein Heidbuchel | Q90710858 |
| | Harry J. G. M. Crijns | Q110902217 |
| P2093 | author name string | Robert-Jan van Geuns | |
| | Joris Ector | |
| | Gillian Ainslie | |
| P2860 | cites work | ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Gui | Q33156283 |
| | Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, | Q34125322 |
| | Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment | Q34235968 |
| | HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis | Q34419644 |
| | Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance. | Q36477873 |
| | Magnetic Resonance Imaging as a Predictor of Survival Free of Life-Threatening Arrhythmias and Transplantation in Cardiac Sarcoidosis | Q36956707 |
| | Risk stratification for major adverse cardiac events and ventricular tachyarrhythmias by cardiac MRI in patients with cardiac sarcoidosis | Q37156444 |
| | Detection of myocardial damage in patients with sarcoidosis | Q37424841 |
| | Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. | Q37640011 |
| | Comprehensive Cardiovascular Magnetic Resonance Assessment in Patients With Sarcoidosis and Preserved Left Ventricular Ejection Fraction | Q38788885 |
| | Cardiac Sarcoidosis: The Impact of Age and Implanted Devices on Survival | Q39404455 |
| | CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis | Q39450583 |
| | Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping | Q42550995 |
| | The utility of delayed-enhancement magnetic resonance imaging for identifying nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. | Q43229979 |
| | The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy. | Q44566178 |
| | Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias | Q45003855 |
| | Right ventricular involvement in cardiac sarcoidosis demonstrated with cardiac magnetic resonance | Q46775971 |
| | Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis | Q47367631 |
| | Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation. | Q51138769 |
| | Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. | Q51270115 |
| | High mass (>18g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis. | Q53035924 |
| | Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis. | Q53066017 |
| | Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death. | Q53330589 |
| | Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. | Q53584684 |
| | Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study | Q57786115 |
| | Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry | Q83284086 |
| | Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosis | Q84925904 |
| | Long-Term Outcomes of Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis | Q88110566 |
| P433 | issue | 1 | |
| P304 | page(s) | 157-171 | |
| P577 | publication date | 2017-10-02 | |
| P1433 | published in | ESC Heart Failure | Q27727376 |
| P1476 | title | Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis | |
| P478 | volume | 5 | |